Find alpha where nobody's looking
We provide institutional-quality research on the companies Wall Street won't cover.
Join thousands of investors hunting for edge in overlooked corners. Unsubscribe anytime.
Undiscovered Companies
We cover small-caps, micro-caps, and nano-caps — companies too small for Wall Street analysts to bother with.
Deep Analysis
Full company deep dives covering financials, competitive landscape, insider activity, and catalysts ahead.
Independent & Unbiased
No conflicts of interest. We never accept payment from the companies we cover. Period.
Asymmetric Upside
Small companies, big potential. Clear ratings, price targets, and risk assessments on every report.
Latest Reports
View allQuoin Pharmaceuticals: A Short-Lived Squeeze Masking Severe Burn Rates
Quoin shares erupted +37% on FDA conditional brand name approval for its lead asset. However, with a $5.3M quarterly cash burn and just $10.8M in liquidity, this micro-cap faces imminent dilution.
Nano Labs: Massive Revenue Contraction Highlights Crypto Mining Vulnerabilities
Despite a 7% premarket bump on volume, Nano Labs' H1 2026 results reveal a devastating 66% revenue collapse to just $0.4M. A supposed Web 3.0 infrastructure play with virtually no revenue.
Youxin Technology: The 444% Growth Engine the Market is Ignoring
Youxin Technology (YAAS) just reported a massive 444% revenue surge to $1.88M for the first half of FY2026. With a potential $20M strategic investment waiting in the wings, this overlooked SaaS micro-cap offers compelling asymmetric upside.
Find alpha where nobody's looking
New small-cap, micro-cap, and nano-cap research delivered to your inbox. Free, forever.